LeadIQ logo
Learn more at LeadIQ.com

Insights

Immunomodulatory Drug Development Enterome focuses on developing immunomodulatory drugs for cancer and immune diseases, presenting a sales opportunity for healthcare institutions and oncology centers looking to expand their treatment options.

Pipeline of Immunotherapies With a pipeline of peptide-based immunotherapies like OncoMimics™, Enterome offers partnership opportunities for pharmaceutical companies seeking innovative cancer treatment solutions.

Clinical Trial Progress The progress of EO2463 in a Phase 2 trial for non-Hodgkin lymphoma and EO2401 in recurrent glioblastoma presents a compelling case for clinical research organizations and investors looking to participate in breakthrough therapies.

Financial Stability and Growth With a revenue range of $10M - 50M and funding of $3.2M, Enterome's financial health signals stability and growth potential, making it an attractive partner for investors, biotech funds, and medical research institutions.

Competitive Landscape Positioning Among similar companies, Enterome stands out with its unique bacterial Mimicry drug discovery platform, offering differentiation and competitive advantage that can be leveraged in collaborations, licensing deals, and acquisitions.

Similar companies to Enterome

Enterome Tech Stack

Enterome uses 8 technology products and services including WordPress, jQuery Migrate, Google Maps, and more. Explore Enterome's tech stack below.

  • WordPress
    Content Management System
  • jQuery Migrate
    Javascript Libraries
  • Google Maps
    Maps
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • Contact Form 7
    Web Platform Extensions

Media & News

Enterome's Email Address Formats

Enterome uses at least 1 format(s):
Enterome Email FormatsExamplePercentage
FLast@enterome.comJDoe@enterome.com
84%
Last@enterome.comDoe@enterome.com
9%
F_Last@enterome.comJ_Doe@enterome.com
5%
First@enterome.comJohn@enterome.com
2%

Frequently Asked Questions

Where is Enterome's headquarters located?

Minus sign iconPlus sign icon
Enterome's main headquarters is located at 94-96 avenue Ledru-Rollin Paris, 75011 FR. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Enterome's phone number?

Minus sign iconPlus sign icon
You can contact Enterome's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Enterome's official website and social media links?

Minus sign iconPlus sign icon
Enterome's official website is enterome.com and has social profiles on LinkedIn.

How much revenue does Enterome generate?

Minus sign iconPlus sign icon
As of November 2024, Enterome's annual revenue reached $35M.

What is Enterome's SIC code NAICS code?

Minus sign iconPlus sign icon
Enterome's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enterome have currently?

Minus sign iconPlus sign icon
As of November 2024, Enterome has approximately 78 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Development Officer, Executive Committee Member: J. R.Chief Scientific Officer: C. B.Chief Business Officer: W. H.. Explore Enterome's employee directory with LeadIQ.

What industry does Enterome belong to?

Minus sign iconPlus sign icon
Enterome operates in the Biotechnology Research industry.

What technology does Enterome use?

Minus sign iconPlus sign icon
Enterome's tech stack includes WordPressjQuery MigrateGoogle MapsOpen GraphMicrosoftYoast SEOBootstrapContact Form 7.

What is Enterome's email format?

Minus sign iconPlus sign icon
Enterome's email format typically follows the pattern of . Find more Enterome email formats with LeadIQ.

How much funding has Enterome raised to date?

Minus sign iconPlus sign icon
As of November 2024, Enterome has raised $3.2M in funding. The last funding round occurred on Oct 30, 2023 for $3.2M.

When was Enterome founded?

Minus sign iconPlus sign icon
Enterome was founded in 2011.
Enterome

Enterome

Biotechnology ResearchParis, France51-200 Employees

Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cross-talk with the human body.

The company is currently developing a pipeline of drug candidates consisting of OncoMimics™ peptide-based immunotherapies for the treatment of cancer. EO2463 is in a Phase 2 clinical trial for indolent non-Hodgkin lymphoma, demonstrating a benign safety profile with encouraging early signs of efficacy. EO2401 has successfully completed a Phase 2 clinical trial in patients with recurrent glioblastoma, and Enterome is currently seeking a pharmaceutical partner to further develop a pivotal trial.

Section iconCompany Overview

Headquarters
94-96 avenue Ledru-Rollin Paris, 75011 FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $3.2M

    Enterome has raised a total of $3.2M of funding over 9 rounds. Their latest funding round was raised on Oct 30, 2023 in the amount of $3.2M.

  • $10M$50M

    Enterome's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $3.2M

    Enterome has raised a total of $3.2M of funding over 9 rounds. Their latest funding round was raised on Oct 30, 2023 in the amount of $3.2M.

  • $10M$50M

    Enterome's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.